Clinical Trials Browser

Phase 2 × Melanoma × Gene Expression Profiling × Clear all

NCT00466687 2013-07-22

Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma

Phase 2 Completed

34 enrolled 10 charts

Melanoma